IP Library Granted Patent US 11,266,548
Granted Patent B2
US 11,266,548 · App. 15/672,571 · Granted Mar 8, 2022

Wound dressing

Inventors: Colin Bradford (Keighley, GB); Brian John Hamerslagh (Higher Runcorn, GB)
Assignee: ADVANCED MEDICAL SOLUTIONS LIMITED
A61F13/53756A61F13/0203A61F13/023A61F13/0253A61F13/0259A61L15/58A61L15/60A61L2300/206A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,266,548
App. No.
15/672,571
Granted
Mar 8, 2022
Kind
B2
Abstract

The present invention relates to wound dressings which are particularly useful (but not necessarily exclusively) on moderate to heavily exuding wounds comprising: an absorbent pad having a first major face comprised of absorbent material and configured for wound contact, and a second major face opposed to the first major face; and a backing layer bonded to the second major face of the pad; wherein the pad and the backing layer are sized such that the backing layer extends beyond the periphery of the pad, thereby defining a margin; wherein the margin of the backing layer is provided with a first adhesive for adhering the backing layer to skin; and wherein a layer of second, low trauma adhesive is provided on, and in direct contact with, the first major face of the pad for adhering the pad to a wound, said layer of second, low trauma adhesive being configured to allow passage of exudate from the wound to the absorbent pad.

Claims (22)

1. A wound dressing comprising:

an absorbent pad having a first major face comprised of absorbent material and configured for wound contact, and a second major face opposed to the first major face; and

a backing layer bonded to the second major face of the absorbent pad,

wherein the absorbent pad and the backing layer are sized such that the backing layer extends beyond the periphery of the absorbent pad, thereby defining a margin,

wherein the margin of the backing layer is provided with a first adhesive for adhering the backing layer to skin and the first adhesive has a peel strength of 3.0N/2.5 cm to 7.0N/2.5 cm,

wherein a layer of a second adhesive is provided on, and in direct contact with, the first major face of the absorbent pad for adhering the absorbent pad to a wound, and

wherein the second adhesive is a silicone-based adhesive and has a peel strength of 0.1N/2.5 cm to 1.0N/2.5 cm said layer of the second adhesive being configured to allow passage of exudate from the wound to the absorbent pad and being a discontinuous layer with an open area of greater than 50%.

2. The wound dressing according to claim 1 , wherein the layer of the second adhesive is printed onto the first major face of the absorbent pad.

3. The wound dressing according to claim 1 , wherein the first adhesive is selected from acrylic-based adhesives, aqueous-based adhesives, and hydrocolloids.

4. The wound dressing according to claim 1 , wherein the margin of the backing layer and/or the first major face of the absorbent pad is provided with an antimicrobial agent.

5. The wound dressing according to claim 4 , wherein the antimicrobial agent is selected from silver, silver compounds, iodine, iodine compounds, or polyhexamethylene biguanide (PHMB).

6. The wound dressing according to claim 1 , wherein the margin of the backing layer and/or the first major face of the absorbent pad is provided with an anti-biofilm agent.

7. A process for manufacturing the wound dressing according to claim 1 , the process comprising the steps of:

(a) providing the backing layer;

(b) providing the absorbent pad having the first major face comprised of absorbent material and configured for wound contact, and the second major face comprised of absorbent material; and

(c) bonding the second major face of the absorbent pad of absorbent material to the backing layer,

wherein the absorbent pad is provided with a layer of a second adhesive on, and in direct contact with, the first major face of the absorbent pad,

wherein the second adhesive is a silicone-based adhesive and has a peel strength of 0.1N/2.5 cm to 1.0N/2.5 cm,

wherein the layer of the second adhesive is a discontinuous layer with an open area of greater than 50%,

wherein the absorbent pad and the backing layer are sized such that the backing layer extends beyond the periphery of the absorbent pad, thereby defining the margin, and

wherein the margin of the backing layer is provided with the first adhesive for adhering the backing layer to skin and the first adhesive has a peel strength of 3.0N/2.5 cm to 7.0N/2.5 cm.

8. The process for manufacturing a wound dressing according to claim 7 , wherein the first major face of the absorbent pad is provided with the layer of the second adhesive prior to bonding the second major face of the absorbent pad of absorbent material to the backing layer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2019
From: BRADFORD, COLIN; HAMERSLAGH, BRIAN JOHN
To: ADVANCED MEDICAL SOLUTIONS LIMITED
Reel/Frame 049051/0024 →
Priority Claims (1)
GB 1613744 · Aug 10, 2016 · national
Continuity (1)
Related Publication 20180042789A1 · Feb 15, 2018